Dr Pierre Martin-Hirsch

Consultant Gynaecological Oncologist and Gynaecologist Job title: Consultant Gynaecological Oncologist and Gynaecologist

Department: Obstetrics and Gynaecology

Telephone number: 01772 524442

Primary medical qualification: MBCHB

Other qualifications: BSFROG MD

Year of registration: 1987

GMC number: 420391

Career history:

Specialist training in obstetrics and gynaecology, NW Deanery .
Wellbeing Research Fellow, St James's University Hospital, Leeds
RCOG Subspecialty Trainee/ Lecturer in Gynaecological Oncology, Manchester University / Christie / St Mary’s Hospital .
Consultant Gynaecological Oncologist and Gynaecologist for Lancashire Teaching Hospitals NHS Foundation Trust (2001-present),

Trust Lead for Gynaecological Oncology

Hon Professor Lancaster University , Hon SL UCLAN,  Editor BJOG & Secretary of British Colposcopy Society, Executive Board of International Federation of Colposcopy , North West Coastal research network lead for Reproductive Health and Gynaecological Oncology

Specialist areas: Gynaecological oncology; colposcopy; vulval / vaginal precancer; oncology training

Specialist Interests: Minimal access surgery,  Vulval disorders , colposcopy, ovarian cancer surgery, patient information

Research interests: Evidence Based Practice  in Gynaecological oncology, Imaging, Surgery in ovarian Cancer, Follow-up care, Patient information, Translational research, outcomes after treatment of cervical pre-cancer. >100 published papers. Supervision of academic trainees, clinical research fellows undertaking MDs, PHD students.

Clinics: Gynaecological Oncology Clinic; Colposcopy Clinic; Vulva CLinic; Gynaecology Clinic

Improving Outcomes in Gynaecological Oncology;
H.C. Kitchener, P.L. Martin-Hirsch 1997 NHS Executive

Pilot Study of Photodynamic Therapy For VIN / CIN
P.L. Martin-Hirsch, HC. Kitchener 1997 Central Manchester R+D

Supra-regional Audit of Maternity Care for Pregnant Adolescents
M.W. Seif, P.L. Martin-Hirsch, M. Maresh 1998 North West R+D
R.C.T. evaluating strategies to improve compliance for colposcopyA. Tomlinson, P.L. Martin-Hirsch 1998

Central Manchester R+D
R.C.T evaluating a novel collection device for cervical cytology
P.L. Martin-Hirsch, H. Kitchener 2000   Ampersand International

Cochrane / Systematic Reviews in Cervical Screening
P.L. Martin-Hirsch., M. Arbyn  2005   Cochrane Collaboration   
Characterisation of cervical cells employing photothermal micro-spectroscopy +
Characterisation of DNA adducts in endometrium  2005+2006 
P.L. Martin-Hirsch, F. Martin .LTHT and Rosemere Cancer Charity
Synucleins as Biomarkers and Potential Targets for Intervention in Cancer Progression
Dr. O El-Agnaf, P.Martin-Hirsch, S Aswad, F Martin  2005
Terry Fox Fund for Cancer Research
Human Ovarian Cancer: Stem Cells & Drug Resistance 2006

Professor Hassan T Hassan, P.L. Martin-Hirsch
NHS Cochrane Collaboration Programme Grant Scheme
Diagnosis and treatment of gynaecological cancer: improving the evidence for the NHS 2007

Khalid Khan, Sudha Sundhar, Pierre Martin-Hirsch, Trcey Roberts, Peter Guest Clinical Effectiveness of PET-CT imaging in restaging cervical cancer: systematic review and economic modelling:  HTA  June 2010

Andrea Rockall, Jon Hill, Pierre Martin-Hirsch, Sundha Sudhar, Richard Edmunson and Colleagues Prospective study evaluating PET in diagnosing lymph node disease in uterine and cervical cancer: Preston / Barts / Cambridge / Birmingham CRUK funded Nov 2010

C. Williams, P. Martin-Hirsch, R. Naik, J. Morrison S. Kehoe  Optimising care, diagnosis and treatment pathways to ensure cost effectiveness and best practice in gynaecological cancer: improving the evidence for the NHS: NIHR Cochrane Collaboration Programme Grant Scheme Jan 2011
K. Beaver, P. Martin-Hirsch  A.Tomlinson, S Williamson, C. Sutton Comparing hospital and telephone follow-up for women treated for endometrial cancer (ENDOCAT: Endometrial Cancer telephone follow-up trial. RFPB April 2011
Towards disease diagnosis through spectrochemical imaging of tissue architecture.

Engineering and Physics Research Council April 2013 :  Weightman and colleagues.

Liverpool / Lancaster Universities I am a clinical partner with Lancashire  Teaching Hospitals as the healthcare partner
Development of multimedia patient information resources for all cancers; Rosemere Cancer Charity 2014


Back to the list

Our First High BMI Patient Undergoes Robotic Surgery

Our First High BMI Patient Undergoes Robotic Surgery

Robotic surgery has successfully treated a cancer patient with a high BMI for the first time at the Cancer Centre at Lancashire Teaching Hospitals NHS Foundation Trust.

Keyhole procedures, which are less invasive and speed up recovery, can be inappropriate for patients with a high BMI, and open surgery may not be an option either due to the increased risks.

The arrival of the DaVinci Xi robot at the Cancer Centre at Lancashire Teaching Hospitals has made surgery for more patients with a high BMI possible, saving lives and improving outcomes. The Cancer Centre was the first hospital in the North of England to secure the latest advanced robotic surgical system to treat patients across the whole of Lancashire and South Cumbria, that would improve outcomes for our patients. The funding for the robot is being raised through an ongoing fundraising appeal launched by the Rosemere Cancer Foundation.

Lynda Prescott, a womb cancer patient who also has a high BMI, was treated by the Cancer Centre team using the new robot.

Commonly, such patients who have open surgery would be in hospital for 10-20 days. However, Lynda was able to go home after just 48 hours.

Lynda said: “I have nothing but praise for all of the staff at Lancashire Teaching Hospitals. I can’t thank them enough for the care that I received. They were open and honest with me throughout the whole process, and explained everything to me which really put me at ease and didn’t make me at all nervous for the robotic procedure. I would especially like to thank Dr Martin-Hirsch who has all of the time in the world for his patients, and is just an absolutely amazing man. My procedure went really well and recovery is going well just a few weeks following this. There could have been a lot of problems as I do have a high BMI, but I’ve only been left with a few tiny cuts so I’m really happy. You’re in real safe hands at Preston Hospital.”

Pierre Martin-Hirsch, Consultant Gynaecological Cancer Surgeon at the Cancer Centre at Lancashire Teaching Hospitals NHS Foundation Trust said: “I am extremely pleased that we can now perform gynaecological surgery on patients with a high BMI using the robot.  This allows us to perform key hole surgery with confidence on patients with a high BMI, reducing the risks and dramatically improving their recovery.”

Alex Robson, Clinical Nurse Specialist at Lancashire Teaching Hospitals NHS Foundation Trust said: “The robotic surgery is delivering great results, from reducing readmission after surgery to a reduction in post-operative pain.  When patients come back to us for follow up appointments, they have repeatedly told me how well they feel and how good their recovery has been, which is fantastic to hear as their specialist nurse.”

To donate to the Rosemere Cancer Foundation 20th Anniversary Appeal to help fund the robot please visit www.rosemere.org.uk or call 01772 522913.